The aim of this study was to develop novel surface-modified poly(ether sulfone) (PES) ultra-filtration (UF) membranes for removal of endocrine disrupting chemicals (EDCs) and pharmaceutical and personal care products (PPCPs).
No takes yet. Share an insight, caveat, or question.
Rana et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: